Finally, circ-CDYL combined with HDGF and HIF1AN performed better than AFP in predicting HCC at early but not advanced stages, holding promise as a biomarker for the surveillance of early HCCs. The gene discussed is AFP; the disease is hepatocellular carcinoma.